Skip to main content
Log in

Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats

  • Original Articles
  • Nephrotoxicity, Cisplatin, Mannitol, Acetazolamide
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The anticancer drug cisplatin has been known to produce severe renal lesions characterized by high levels of blood urea nitrogen (BUN), toxic nephrosis, and platinum (Pt) retention in the kidney. The effect of IV pretreatment with acetazolamide (ACZ) 30 min before or mannitol (MAN) immediately prior to IP administration of 5 mg/kg cisplatin on Pt excretion, tissue distribution, and nephrotoxicity was investigated in male F344 rats.

ACZ pretreatment reduced the cisplatin-induced nephrotoxicity, as indicated by only a slight elevation of BUN, a milder histopathologic lesion, and a more rapid recovery of renal function and structure. Although MAN-pretreated animals exhibited similar changes in BUN to ACZ-pretreated animals, the renal damage was similar to that seen in aninals treated with cisplatin alone. A reduction of kidney Pt content was observed with both diuretics, although there was significantly less retention after ACZ pretreatment.

The diuretic ACZ was more effective than MAN in reducing the renal lesions induced by cisplatin and it might be clinically useful in preventing cisplatin nephrotoxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Borch RF, Pleasants ME (1979) Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamide rescue in a rat model. Proc Natl Acad Sci USA 76:6611

    PubMed  Google Scholar 

  2. Crocker CL (1967) Rapid determination of urea nitrogen in serum or plasma without deproteinization. Am J Med Technol 33:361

    PubMed  Google Scholar 

  3. Cvitkovic E, Spaulding J, Bethune V, Martin J, Whitmore WF (1977) Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cancer 39:1357

    PubMed  Google Scholar 

  4. Daley-Yates PT, McBrien DC (1983) Cisplatin metabolites: A method for their separation and for measurement of their renal clearance in vivo. Biochem Pharmacol 32:181

    Article  PubMed  Google Scholar 

  5. DcSimone PA, Yancey RS, Coupal JJ, Butts JD, Hoeschele JD (1979) Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II). Cancer Treat Rep 63:951

    PubMed  Google Scholar 

  6. Hayes DM, Cvitkovic E, Golbey RB, Scheiner E, Helson L, Krakoff IH (1977) High-dose cis-platinumdichloride: amelioration of renal toxicity by mannitol diuresis. Cancer 39:1372

    PubMed  Google Scholar 

  7. Howell SB, Taetle R (1980) Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 64:611

    PubMed  Google Scholar 

  8. Lehane D, Winston A, Gray R, Daskal Y (1979) The effects of diuretic pretreatment on clinical, morphological and ultrastructural cis-platinum-induced nephrotoxicity. Int J Radiat Oncol Biol Phys 5:1393

    PubMed  Google Scholar 

  9. LeRoy AF, Wehling ML, Sponseller HL, Litterst CL, Gram TE, Guarino AM, Becker DA (1977) Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem Med 18:184

    Article  PubMed  Google Scholar 

  10. Litterst CL, Schweitzer VG (1984) Increased tissue deposition and decreased excretion of platinum following administration of cisplatinum to cisplatinum-pretreated animals. Cancer Chemother Pharmacol 12:46

    Article  PubMed  Google Scholar 

  11. Osman NM, Copley MP, Litterst CL (1984) Amelioration of cisplatinum-induced nephrotoxicity by the diuretic acetazolamide in F344 rats. Cancer Treat Rep (in press)

  12. Ostrow S, Egorin MJ, Hahn D, Markus S, Aisner J, Chang P, LeRoy A, Bachur NR, Wiernik PH (1981) High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity. Cancer Treat Rep 65:73

    Google Scholar 

  13. Pera MF, Zook BC, Harder HC (1979) Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum(II) in rats. Cancer Res 39:1269

    PubMed  Google Scholar 

  14. Thiel A, Brunner F, Wunderlich P, Huguenin M, Bienko B, Torhorst J, Haefeli L, Kirchertz EJ, Peters G (1976) Protection of rat kidneys against HgCl2-induced acute renal failure by induction of high urine flow without renin supression. Kidney Int 10:S 191

    Google Scholar 

  15. Walker EM, Gale GR (1981) Methods for reduction of cisplatin nephrotoxicity. Ann Clin Lab Sci 11:397

    PubMed  Google Scholar 

  16. Ward JM, Grabin ME, Berlin E, Young DM (1977) Prevention of renal failure in rats receiving cis-diamminedichoroplatinum(II) by administration of furosemide. Cancer Res 37:1238

    PubMed  Google Scholar 

  17. Weiner IM, Washington JA, Mudge GH (1959) Studies on the renal excretion of salicylate in the dog. Bull Johns Hopkins Hosp 105:284

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Osman, N.M., Copley, M.P. & Litterst, C.L. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats. Cancer Chemother. Pharmacol. 13, 58–62 (1984). https://doi.org/10.1007/BF00401449

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00401449

Keywords

Navigation